Literature DB >> 29476356

Coffee consumption and risk of rare cancers in Scandinavian countries.

Marko Lukic1,2, Lena Maria Nilsson3, Guri Skeie4, Bernt Lindahl5, Tonje Braaten4.   

Abstract

Studies on the association between heavy coffee consumption and risk of less frequently diagnosed cancers are scarce. We aimed to quantify the association between filtered, boiled, and total coffee consumption and the risk of bladder, esophageal, kidney, pancreatic, and stomach cancers. We used data from the Norwegian Women and Cancer Study and the Northern Sweden Health and Disease Study. Information on coffee consumption was available for 193,439 participants. We used multivariable Cox proportional hazards models to calculate hazard ratios (HR) with 95% confidence intervals (CI) for the investigated cancer sites by category of total, filtered, and boiled coffee consumption. Heavy filtered coffee consumers (≥ 4 cups/day) had a multivariable adjusted HR of 0.74 of being diagnosed with pancreatic cancer (95% CI 0.57-0.95) when compared with light filtered coffee consumers (≤ 1 cup/day). We did not observe significant associations between total or boiled coffee consumption and any of the investigated cancer sites, neither in the entire study sample nor in analyses stratified by sex. We found an increased risk of bladder cancer among never smokers who were heavy filtered or total coffee consumers, and an increased risk of stomach cancer in never smokers who were heavy boiled coffee consumers. Our data suggest that increased filtered coffee consumption might reduce the risk of pancreatic cancer. We did not find evidence of an association between coffee consumption and the risk of esophageal or kidney cancer. The increased risk of bladder and stomach cancer was confined to never smokers.

Entities:  

Keywords:  Bladder; Boiled; Cancer; Coffee; Esophageal; Filtered; Kidney; Pancreatic; Prospective cohort study; Stomach

Mesh:

Substances:

Year:  2018        PMID: 29476356     DOI: 10.1007/s10654-018-0369-9

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  45 in total

1.  Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.

Authors:  L Gu; F J Gonzalez; W Kalow; B K Tang
Journal:  Pharmacogenetics       Date:  1992-04

2.  Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care.

Authors:  L Weinehall; C G Hallgren; G Westman; U Janlert; S Wall
Journal:  Scand J Prim Health Care       Date:  1998-09       Impact factor: 2.581

3.  Carcinogenicity of drinking coffee, mate, and very hot beverages.

Authors:  Dana Loomis; Kathryn Z Guyton; Yann Grosse; Béatrice Lauby-Secretan; Fatiha El Ghissassi; Véronique Bouvard; Lamia Benbrahim-Tallaa; Neela Guha; Heidi Mattock; Kurt Straif
Journal:  Lancet Oncol       Date:  2016-06-15       Impact factor: 41.316

4.  Comparison of diet measures from a food-frequency questionnaire with measures from repeated 24-hour dietary recalls. The Norwegian Women and Cancer Study.

Authors:  Anette Hjartåker; Lene Frost Andersen; Eiliv Lund
Journal:  Public Health Nutr       Date:  2007-03-15       Impact factor: 4.022

5.  Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions.

Authors:  Göran Hallmans; Asa Agren; Gerd Johansson; Anders Johansson; Birgitta Stegmayr; Jan-Håkan Jansson; Bernt Lindahl; Olle Rolandsson; Stefan Söderberg; Mats Nilsson; Ingegerd Johansson; Lars Weinehall
Journal:  Scand J Public Health Suppl       Date:  2003       Impact factor: 3.021

6.  A urinary metabolite ratio that reflects systemic caffeine clearance.

Authors:  M E Campbell; S P Spielberg; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1987-08       Impact factor: 6.875

7.  Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.

Authors:  Eero Pukkala; Aage Andersen; Göran Berglund; Randi Gislefoss; Vilmundur Gudnason; Göran Hallmans; Egil Jellum; Pekka Jousilahti; Paul Knekt; Pentti Koskela; P Pentti Kyyrönen; Per Lenner; Tapio Luostarinen; Arthur Löve; Helga Ogmundsdóttir; Pär Stattin; Leena Tenkanen; Laufey Tryggvadóttir; Jarmo Virtamo; Göran Wadell; Anders Widell; Matti Lehtinen; Joakim Dillner
Journal:  Acta Oncol       Date:  2007       Impact factor: 4.089

8.  Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein.

Authors:  Larry G Higgins; Christophe Cavin; Ken Itoh; Masayuki Yamamoto; John D Hayes
Journal:  Toxicol Appl Pharmacol       Date:  2007-09-26       Impact factor: 4.219

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  A prospective study of coffee intake and pancreatic cancer: results from the NIH-AARP Diet and Health Study.

Authors:  K A Guertin; N D Freedman; E Loftfield; R Z Stolzenberg-Solomon; B I Graubard; R Sinha
Journal:  Br J Cancer       Date:  2015-09-24       Impact factor: 7.640

View more
  6 in total

1.  Coffee consumption and risk of renal cancer: a meta-analysis of cohort evidence.

Authors:  Jongeun Rhee; Rachel K Lim; Mark P Purdue
Journal:  Cancer Causes Control       Date:  2021-10-22       Impact factor: 2.506

2.  Coffee consumption and cancer risk: a Mendelian randomisation study.

Authors:  Paul Carter; Shuai Yuan; Siddhartha Kar; Mathew Vithayathil; Amy M Mason; Stephen Burgess; Susanna C Larsson
Journal:  Clin Nutr       Date:  2022-08-25       Impact factor: 7.643

3.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

4.  Antitumor Effects of Freeze-Dried Robusta Coffee (Coffea canephora) Extracts on Breast Cancer Cell Lines.

Authors:  Ayelén D Nigra; Deborah de Almeida Bauer Guimarães; César G Prucca; Otniel Freitas-Silva; Anderson J Teodoro; Germán A Gil
Journal:  Oxid Med Cell Longev       Date:  2021-05-18       Impact factor: 6.543

5.  Association between coffee consumption and risk of bladder cancer in a meta-analysis of 16 prospective studies.

Authors:  Zhi-Wei Dai; Ke-Dan Cai; Fu-Rong Li; Xian-Bo Wu; Guo-Chong Chen
Journal:  Nutr Metab (Lond)       Date:  2019-09-13       Impact factor: 4.169

6.  Coffee Consumption and Pancreatic Cancer Risk: A Meta-Epidemiological Study of Population-based Cohort Studies.

Authors:  Jong-Myon Bae; Sung Ryul Shim
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.